Clinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of Joep Muijrers.
Muijrers most recently served as a partner and portfolio manager at Life Sciences Partners, a trans-Atlantic investor group with an exclusive focus on the life science industry.
During his 11 years at the company, Muijrers’ responsibilities saw him help several companies strengthen its biopharmaceutical status.
Daphne Zohar, founder and chief executive officer of PureTech Health, said: “We are delighted to have Joep join PureTech Health and bring his diverse experience in life sciences and impressive track record of significant value creation to our team as we enter this next important phase of our growth.”
Muijrers has worked with pharmaceutical clients such as Kite Pharma, Ablynx and Juno Therapeutics, and said: “I am thrilled to join PureTech Health, one of the most exiciting and unique biopharma companies I have come across in my career.”
In his new role, Muijrers will be take the helm of all aspects of the company’s finances, including capital markets strategy and execution, driving monetisation events for growth stage affiliates, strategic and financial planning and financial reporting.